West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter. Asian Pacific Journal of Cancer Prevention 1513-7368 21 10 2020 10 01 New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study 2903 2911 89291 10.31557/APJCP.2020.21.10.2903 EN Hiroya Iida Department of Surgery, Shiga University of Medical Science, Otsu, Japan. Masaki Kaibori Department of Surgery, Kansai Medical University, Hirakata, Japan. Fumitoshi Hirokawa Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan. Yoshihiro Inoue Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan. Masaki Ueno Second Department of Surgery, Wakayama Medical University, Wakayama, Japan. Kousuke Matsui Department of Surgery, Kansai Medical University, Hirakata, Japan. Morihiko Ishizaki Department of Surgery, Kansai Medical University, Hirakata, Japan. Shogo Tanaka Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. Shigekazu Takemura Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. Takeo Nomi Department of Surgery, Nara Medical University, Kashihara, Japan. Daisuke Hokutou Department of Surgery, Nara Medical University, Kashihara, Japan. Takehiro Noda Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan. Hidetoshi Eguchi Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan. Takuya Nakai Department of Surgery, Faculty of Medicine, Kinki University, Osaka-sasayama, Japan. Hiromitsu Maehira Department of Surgery, Shiga University of Medical Science, Otsu, Japan. Haruki Mori Department of Surgery, Shiga University of Medical Science, Otsu, Japan. Masaji Tani Department of Surgery, Shiga University of Medical Science, Otsu, Japan. Shoji Kubo Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. Journal Article 2020 02 23 Background: Hepatic resection (HR) is not recommended for intermediate-stage hepatocellular carcinoma (HCC) by the Barcelona Clinic Liver Cancer criteria. We examined the prognostic factors of HR for intermediate-stage HCC and developed new HR criteria for intermediate-stage HCC. Methods: A total of 110 patients who underwent HR without any prior treatment for intermediate-stage HCC between January 2007 and December 2012 were enrolled at eight university hospitals. The outcomes and prognostic factors of HR were evaluated to develop new HR criteria. Results: In terms of tumor size and number, the most significant prognostic factors were within the up-to-seven criteria. Furthermore, serum albumin level ≥35 g/L and serum alpha-fetoprotein (AFP) level   https://journal.waocp.org/article_89291_9de109eb1b46eef6756523b48f1f7bbd.pdf